MENU
BCYC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Bicycle Therapeutics (BCYC) Ownership - Who owns Bicycle Therapeutics?

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles... Show more

Profile

Industry
N/A
Address
Granta Park, Great Abington
Phone
+44 1223261503
Employees
284
Web
https://www.bicycletherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
667.8M
P/E Ratio
N/A
Total Cash
890.86M
Projected Growth
N/A
Total Debt
11.09M
Revenue
36.9M
Risk (Beta)
1.58
Dividend Yield
N/A
Total Cash/Share
12.87
Total Debt/Equity
N/A
Revenue/Share
0.61 USD as % of share price

Fundamentals

BCYC
Capitalization
668M
P/E Ratio
N/A
Risk (Beta)
1.58
Dividend Yield
N/A
Total Cash
891M
Total Cash/Share
12.87
Total Debt
11.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.61%
Revenue
36.9M
ROE
N/A
Book Value
831M
P/B Ratio
0.84
Cash Flow
N/A
Earnings
-3.28
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
890K
Current Ratio
17.13
Current Revenue Per Employee
9422.53
Dividends Per Share - Security
N/A
EBITDA
-160.02M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-20.33
Shares Held By Institutions
991M
Shares Outstanding - Current
69.2M
Total Liabilities
166M
Total Volume MTD
N/A
Value
1
Gain YTD
-31.071
View a ticker or compare two or three
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company, which engages in the development of biopharmaceuticals.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Granta Park, Great Abington
Phone
+44 1223261503
Employees
284
Web
https://www.bicycletherapeutics.com